Incidence and implications of anti-rituximab antibodies in nephropathies and other immune-mediated diseases: a narrative review
Rituximab is a chimeric anti-CD20 monoclonal antibody widely used in immune-mediated and hematologic diseases, but its efficacy may be limited by the development of anti-rituximab antibodies (ADAs). This narrative review summarizes current evidence on …